Calvin: Providers spend $400 tracking patients with under 10% data yield
Nehomitza Calvin · Will VCs Invest in Vital Audio's Voice-Based Health Monitoring Tech? · Sep 11, 2024 · at 10:59
Vital Audio founder Nehomitza Calvin describes industry inefficiencies in traditional remote patient monitoring while pitching investors on The Pitch.
0:00 / 0:11exact quote · 11.3s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“So, on average, a provider spends 400 dollars to track a patient. With less than 10% yield of good data to actually use.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Nehomitza Calvin
Calvin: Vital Audio achieves 96% accuracy compared to gold standard ECG
“So we conducted two studies in partnerships with NYU Langone Cardiology Department and Zip Care Clinic. Reached more than 500 participants across the New York metropolitan area. The technology actually performs at 96% accuracy compared to gold Standard ECG.”
Calvin: FDA stated Vital Audio is first vocal-frequency tech encountered
“The FDA has actually shared that it's the first technology that they have encountered that takes in vocal frequencies or signals.”
Calvin: Vital Audio receives FDA non-significant risk designation for data acquisition
“We received a non-significant risk designation from the FDA, and we wanted to actually put the technology forward To the general population, because the technology, the more data is actually processing, the better it actually becomes. So, we submitted the data…”
Calvin: Vital Audio may complete FDA 510(k) in 6-8 months
“So that we're anticipating maybe a period of six to eight months to actually complete that.”